Gilead Sciences · 15 hours ago
Post Doc Scientist- Oncology
Gilead Sciences is dedicated to creating a healthier world by tackling significant diseases such as cancer. They are seeking a highly motivated Postdoctoral Research Fellow to join their oncology research team, focusing on understanding resistance mechanisms to cancer therapeutics and contributing to high-quality scientific publications.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Develop and characterize in vitro and in vivo resistance models using cancer cell lines and mouse xenograft tumor models
Perform multi-omics profiling (WES, RNA-seq, methylation analysis and other) to identify molecular alterations associated with acquired and intrinsic resistance
Conduct functional validation of candidate resistance mechanisms using gene editing and gain-of-function systems
Think critically and creatively while applying strong organizational and planning skills
Actively participate in cross-functional group collaborations, present at company internal meetings as well as at national or international scientific conferences
Qualification
Required
Ph.D. in Cancer Biology, Molecular Biology, Genetics, or a related field
Strong background in cancer pharmacology, drug resistance, and functional genomics
Hands-on experience with CRISPR/Cas9, lentiviral systems, and mouse xenograft models
First authorship in publications in peer-reviewed journals or accepted in a peer-reviewed journal
Demonstrated ability to work independently and collaboratively in a multidisciplinary team
Excellent communication and scientific writing skills
Preferred
Proficiency in next-generation sequencing data analysis and interpretation
Benefits
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2026-01-16
FierceBiotech
2026-01-16
Company data provided by crunchbase